97 related articles for article (PubMed ID: 3054754)
21. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the biliary excretion of penicillin G. (author's transl)].
Brogard JM; Arnaud JP; Dauchel J; Pinget M; Lavillaureix J
Pathol Biol (Paris); 1979 Sep; 27(7):403-10. PubMed ID: 388319
[TBL] [Abstract][Full Text] [Related]
23. The biliary and renal elimination of the new muscarinic-1-antagonist AWD 26-06 in volunteers with T-tube after cholecystectomy.
Trausch B; Terhaag B; Gebhardt M; Richter K; Oertel R
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):508-9. PubMed ID: 1490811
[TBL] [Abstract][Full Text] [Related]
24. Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration.
Dan M; Verbin N; Gorea A; Nagar H; Berger SA
Eur J Clin Pharmacol; 1987; 32(2):217-8. PubMed ID: 3582488
[TBL] [Abstract][Full Text] [Related]
25. [Experimental and clinical evaluation of the biliary elimination of ceftazidime].
Brogard JM; Jehl F; Blickle JF; Monteil H; Arnaud JP
Pathol Biol (Paris); 1986 May; 34(5):332-8. PubMed ID: 3534701
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
27. [Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose].
Flory PJ; Krug G; Lorenz D; Mennicke WH
Planta Med; 1980 Mar; 38(3):227-37. PubMed ID: 7367491
[No Abstract] [Full Text] [Related]
28. Disposition of ciprofloxacin in the isolated perfused rat liver.
Abadìa AR; De Francesco L; Guaitani A
Drug Metab Dispos; 1995 Feb; 23(2):197-200. PubMed ID: 7736911
[TBL] [Abstract][Full Text] [Related]
29. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
30. [Experimental and clinical study of the biliary elimination of mezlocillin (author's transl)].
Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
Pathol Biol (Paris); 1981 Sep; 29(7):405-10. PubMed ID: 6457274
[TBL] [Abstract][Full Text] [Related]
31. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
Siefert HM; Maruhn D; Scholl H
Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
[TBL] [Abstract][Full Text] [Related]
33. Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
Brogard JM; Caro-Sampara F; Westphal JF; Blickle JF; Jehl F
Drugs Exp Clin Res; 1994; 20(6):247-55. PubMed ID: 7758397
[TBL] [Abstract][Full Text] [Related]
34. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
[TBL] [Abstract][Full Text] [Related]
35. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
36. Biliary elimination of aspirin after oral and intravenous administration in patients.
Brune K; Nuernberg B; Schneider HT
Agents Actions Suppl; 1993; 44():51-7. PubMed ID: 8372735
[TBL] [Abstract][Full Text] [Related]
37. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
38. [Biliary excretion of apalcillin. Experimental study and evaluation in man].
Brogard JM; Adloff M; Pinget M; Dorner M; Lautier F
Pathol Biol (Paris); 1985 Feb; 33(2):121-8. PubMed ID: 3889782
[TBL] [Abstract][Full Text] [Related]
39. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
[TBL] [Abstract][Full Text] [Related]
40. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
